HOME >> MEDICINE >> NEWS
Prostate cancer research may be faster with PSA endpoints

A new study from Columbia University Medical Center researchers at NewYork-Presbyterian Hospital/Columbia, who are members of the Southwest Oncology Group (SWOG), suggests that certain changes in prostate-specific antigen (PSA) levels may serve as surrogate endpoints for prostate cancer survival. Researchers looking to speed up the process of clinical trials have suggested that these biomarkers could be used to measure treatment efficacy.

Currently, the U.S. Food and Drug Administration accepts only survival as an endpoint of measure. Survival as a primary endpoint was used in phase III studies of novel chemotherapeutic drugs for men with androgen-independent prostate.

Daniel P. Petrylak, M.D., associate professor of medicine at Columbia University College of Physicians & Surgeons and director of the genitourinary oncology program at NewYork-Presbyterian/Columbia, together with his research team, retrospectively analyzed results of 551 men with prostate cancer treated in the Southwest Oncology Group Protocol S9916. By reviewing the clinical trial, it was noted that there were several different changes in PSA levels, which could possibly serve as surrogate endpoints for survival.

The authors observed that the risk of death, in men whose serum PSA levels declined by at least 30 percent in the first three months of treatment, was reduced more than 50 percent. Findings are published in the Journal of the National Cancer Institute (April 19, 2006 issue).

"The findings show that PSA levels can be a reliable endpoint measure of prostate cancer treatment efficacy," said Dr. Petrylak, lead investigator. "However, this and other candidate surrogate endpoints must be validated in independent clinical trials of men with prostate cancer."

This study is a follow-up to a landmark phase III trial published in the New England Journal of Medicine (Oct. 7, 2004), by the same Columbia University Medical Center and NewYork-Presbyterian Hos
'"/>

Contact: Elizabeth Streich
eas2125@columbia.edu
212-305-6535
Columbia University Medical Center
18-Apr-2006


Page: 1 2

Related medicine news :

1. Prostate cancer patients see high survival rates with seed implants
2. Prostate cancer treatment increases risk of diabetes and heart disease
3. Prostate treatment decisions based on perception more than fact
4. Prostate cancer test affected by demographic and lifestyle factors
5. Prostate cancer therapy - study suggests new molecular screening theory
6. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
7. Survival differences by race most apparent in advanced stages of breast cancer
8. Stomach cancer rate set to fall further 25 percent over next decade
9. MRI finds breast cancer before it becomes dangerous
10. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
11. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... and DALLAS, Texas (PRWEB) , ... December 05, ... ... again proved its leading SkinPen Precision device is setting a new standard as ... record-setting Aesthetics Everything win. , Each year this award is presented at the ...
(Date:12/5/2018)... ... December 05, 2018 , ... ... leadership training on January 26 at North Monroe Baptist Church, 210 Finks Hideaway ... trainings, part of the agency’s effort to educate and equip faith leaders to ...
(Date:12/5/2018)... ... December 05, 2018 , ... Dr. Jessica Allen of Northern ... LAPIP™ protocol for ailing dental implants in the Fort Collins area. Dr. Allen joins ... to regenerate the bone and tissues lost to gum disease. , "Gum disease is ...
(Date:12/5/2018)... ... December 05, 2018 , ... Definitive Healthcare , the ... today that it was ranked #184 on Deloitte’s Technology Fast 500 list for ... in the fields of technology, media, telecommunications, life science, and energy tech companies ...
(Date:11/29/2018)... BRIGHTON, Mich. (PRWEB) , ... November 29, 2018 , ... ... deodorant, toothbrush, toothpaste, body wash and a razor for distribution to eight Michigan homeless ... an additional $1,500 to one or more of the organizations to be selected by ...
Breaking Medicine News(10 mins):
(Date:11/29/2018)... Fla. (PRWEB) , ... November 29, 2018 , ... ... practitioner-channel dietary supplement company – announced today the launch of the Annatto-E™ product ... annatto plant (Bixa orellana). Backed by clinical research, DFH’s new Annatto-E™ products are ...
(Date:11/29/2018)... ... November 29, 2018 , ... Access ... the company’s powerful electronic forms and eSignatures functionality accessible via tablets, smartphones, and ... bounds in the consumer space and it’s about time hospital solutions caught up,” ...
(Date:11/28/2018)... ... November 28, 2018 , ... ... Israel’s Sheba Medical Center, Tel HaShomer this week to form a collaboration between ... home country, the Democratic Republic of Congo. , On Thursday, November 29, ...
Breaking Medicine Technology:
Cached News: